Hengkang Pharmaceutical, one of the largest manufacturer of Phosphoramidite monomer and nucleotide materails for mRNA IVT, is pleased to announce its participation in the highly anticipated BIO International Convention 2023. This premier event, scheduled to take place from [5th] to [8th] June, will bring together industry pioneers, professionals, and potential clients from around the world at the [Boston Convention and Exhibition Center] in [415 Summer Street, Boston, MA 02210].

Hengkang Pharmaceuticals is committed to the commercial production of raw materials in the pharmaceutical industry, reducing product costs through technological reforms, ensuring stable and reliable quality under the GMP management system, and serving global customers, including primer synthesis, ASO synthesis, siRNA synthesis, and mRNA synthesis.

Main product:

Phosphoramidite, DNA 2'-O-Me Phosphoramidite, 2'-Fluoro Phosphoramidite, 
NTPs, N1-Me pUTP, pUTP,
Cap Analog, GAG Cap, 3'-OMe GAG
Intermeidiate, protected nucleoside(PNS for phosphoramidite), modified nucleoside(2'-O-Me nucleoside, 2'-Fluoro nucleoside)